Fairchild Brothers & Foster

Fairchild Brothers & Foster

Company type	Private
Industry	Pharmaceutical manufacturing
Founded	1880s
Founder	Thomas Fairchild, Samuel W. Fairchild, Macomb G. Foster
Defunct	1946
Fate	Acquired by Winthrop Chemical Company, later part of Sterling Drug, Inc.
Headquarters	New York City , United States
Products	Pharmaceuticals for digestive ailments including Marinol, Phisoderm, Enzymo

Fairchild Brothers & Foster operated as a pharmaceutical manufacturer headquartered in New York City during the 1930s.

History

Thomas Fairchild completed his education at Stratford Academy and earned a degree from the Philadelphia College of Pharmacy. He subsequently worked for Caswell Havard & Company in New York City. Later, he co-founded Fairchild Brothers & Foster alongside his sibling, Samuel W. Fairchild (deceased 1927), and Macomb G. Foster (deceased 1938). Macomb G. Foster was related to Pell William Foster (died 1947), who established the Foster Wheeler corporation, and was the son of William Foster Jr., a former president of multiple New York railroad enterprises and the founder of the Retsof Salt Mining Company in Retsof, New York. Beginning in 1881, Macomb G. Foster maintained an uninterrupted association with Fairchild Brothers & Foster spanning fifty-seven years.

Acquisition

Initially, Winthrop Chemical Company acquired Fairchild Brothers & Foster. Subsequently, in February 1946, Sterling Drug, Inc. purchased Winthrop Chemical Company. Fairchild Brothers & Foster focused on producing pharmaceuticals aimed at treating digestive ailments. Their product line included Marinol, Phisoderm, and Enzymo.

Following the acquisition, Stearns & Company, a subsidiary under Sterling Drug, Inc., assumed responsibility for distributing all but three of the pharmaceuticals originally manufactured by Fairchild Brothers & Foster. The production of Marinol, Phisoderm, and Enzymo was continued by Winthrop Chemical Company, another Sterling subsidiary.

See also

• Sterling Drug, Inc.